Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclo-oxygenase 2 (COX-2), also known as prostaglandin-endoperoxide synthase 2 (PTGS2), is an inducible enzyme that catalyzes the first two steps in the biosynthesis of prostaglandins from arachidonic acid. Prostaglandins are lipid compounds that play key roles in inflammation, pain, fever, and other physiological processes. COX-2 is a major target for nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors ("coxibs"), which are used to treat pain and inflammation.
Inhibition of cyclooxygenase activity, reducing prostaglandin synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclo-oxygenase 2 (COX-2).